RPAM
ARNA
Rhenman & Partners Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-60,000
| Closed | -$3.57M | – | 98 |
|
|
2021
Q3 | $3.57M | Hold |
60,000
| – | – | 0.25% | 82 |
|
|
2021
Q2 | $4.09M | Hold |
60,000
| – | – | 0.28% | 84 |
|
|
2021
Q1 | $4.16M | Sell |
60,000
-10,000
| -14% | -$694K | 0.29% | 79 |
|
|
2020
Q4 | $5.38M | Sell |
70,000
-140,778
| -67% | -$10.8M | 0.44% | 67 |
|
|
2020
Q3 | $15.8M | Hold |
210,778
| – | – | 1.4% | 32 |
|
|
2020
Q2 | $13.3M | Sell |
210,778
-29,222
| -12% | -$1.84M | 1.43% | 29 |
|
|
2020
Q1 | $10.1M | Buy |
240,000
+20,000
| +9% | +$840K | 1.41% | 29 |
|
|
2019
Q4 | $9.99M | Buy |
220,000
+65,000
| +42% | +$2.95M | 1.1% | 40 |
|
|
2019
Q3 | $7.09M | Sell |
155,000
-15,000
| -9% | -$687K | 0.89% | 45 |
|
|
2019
Q2 | $9.97M | Sell |
170,000
-64,558
| -28% | -$3.78M | 1.1% | 38 |
|
|
2019
Q1 | $10.5M | Sell |
234,558
-137,300
| -37% | -$6.16M | 1.23% | 33 |
|
|
2018
Q4 | $14.5M | Buy |
371,858
+5,471
| +1% | +$213K | 1.66% | 24 |
|
|
2018
Q3 | $16.9M | Buy |
366,387
+81,766
| +29% | +$3.76M | 1.69% | 25 |
|
|
2018
Q2 | $12.4M | Sell |
284,621
-1,021
| -0.4% | -$44.5K | 1.27% | 37 |
|
|
2018
Q1 | $11.3M | Sell |
285,642
-100,000
| -26% | -$3.95M | 1.39% | 33 |
|
|
2017
Q4 | $13.1M | Sell |
385,642
-183,849
| -32% | -$6.25M | 1.77% | 22 |
|
|
2017
Q3 | $14.5M | Buy |
+569,491
| New | +$14.5M | 1.85% | 18 |
|